**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 615-20-3 |2-Chlorobenzothiazole | 99.0 | 210-415-0 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully
investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
The toxicological properties of this substance have not been fully
investigated.
Inhalation:
May cause respiratory tract irritation.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Avoid contact with eyes, skin, and clothing. Keep
container tightly closed. Avoid ingestion and inhalation. Use with
adequate ventilation.
Storage:
Keep container closed when not in use. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 615-20-3:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: dark orange
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 141 deg C @ 30.00mmHg
Freezing/Melting Point: 21.00 - 23.00 deg C
Autoignition Temperature: Not available.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.3710g/cm3
Molecular Formula: C7H4ClNS
Molecular Weight: 169.63
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, oxides of
sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 615-20-3: DL3150000
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
2-Chlorobenzothiazole -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 615-20-3: 2
Canada
CAS# 615-20-3 is listed on Canada's DSL List.
CAS# 615-20-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 615-20-3 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/16/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Ruthenium(III) Nitrosyl Chloride Monohydrate
| 18902-42-6 |
|
Hexaammineruthenium(III) Chloride
| 14282-91-8 |
|
1,2-Bis(diphenylphosphino)ethane nickel(II) chloride
| 14647-23-5 |
|
Tris(hydroxymethyl)phosphine
| 2767-80-8 |
|
2-Ethoxybenzaldehyde, 97+%
| 613-69-4 |
|
Methyl 3-Amino-2-Pyrazinecarboxylate, 98%
| 16298-03-6 |
|
Guanidine Hydrochloride without Anticaking Agent, 98%
| 50-01-1 |
|
Bis(Cyclopentadienyl)Osmium
| 1273-81-0 |
|
Scandium(III) Trifluoromethanesulfonate
| 144026-79-9 |
|
Tetraammineplatinum(II) nitrate
| 20634-12-2 |
|
Hydrogen hexachloroplatinate(IV) hexahydrate
| 16941-12-1 |
|
(S)-(-)-alpha-Methoxy-alpha-(Trifluoruomethyl)Phenylacetic Acid
| 17257-71-5 |
|
1,1'-(Methylenedi-p-phenylene)bis[3-(2-hydroxyethyl)]urea
| 7747-61-7 |
|
1,1'-(Methylenedi-p-phenylene)bis[3-(3-hydroxypropyl)]urea
| 20006-61-5 |
|
4-Methyl-2-Oxopentanoic Acid, Sodium Salt
| 4502-00-5 |
|
Cyclohexyltriphenylphosphonium Bromide, 97%
| 7333-51-9 |
|
Benzyltrimethylammonium Bromide
| 5350-41-4 |
|
Dehydroacetic Acid Sodium Salt, 99%
| 4418-26-2 |
|
Tris(2,6-dimethoxyphenyl)phosphine
| 85417-41-0 |
|
1-[1-(4-Chlorophenyl)Cyclobutyl]-3-Methylisobutylamine Hydrochloride
| 84484-78-6 |
|
1-(4-Chlorophenyl)-1-Cyclobutanecarbonitrile
| 28049-61-8 |
|
1,4-Phenylenediacetic acid, 97%
| 7325-46-4 |
|
1-(4-Methoxyphenyl)-1-Cyclopentanecarbonitrile
| 1206-15-1 |
|
15-Hydroxypentadecanoic Acid
| 4617-33-8 |
|
1,1,1-Trifluoro-2-Phenylbuten-2-ol
| 134418-70-5 |
|
1,1,1-Trifluoro-2-Phenylbutyn-2-ol
| 99727-20-5 |
|
3-Hydroxybutyonitrile
| 4368-06-3 |
|
Diacetone-d-glucose, 98+%
| 582-52-5 |
|
3,4-Epoxy-2-phenyl-1,1,1-trifluoro-2-butanol, mixture of
| 351003-37-7 |
|
3-Aminophenylacetylene
| 54060-30-9 |
|
Sodium Pivalate Hydrate, 99%
| 143174-36-1 |
|
Lithium tetrachloropalladate(II) hydrate, 99%
| 15525-45-8 |
|
Chlorobenzene
| 108-90-7 |
|
6-Bromo-1-Hexene, 97%
| 2695-47-8 |
|
Tributyl Citrate, 97%
| 77-94-1 |
|
Potassium tert-butoxide, 20 wt.% solution in THF
| 109-99-9 |
|
L-tert-Leucine-Tert-Butylester Hydrochloride
| 0-01-1 |
|
4-Keto-4,5,6,7-tetrahydrothianaphthene
| 13414-95-4 |
|
6-Hydroxyquinoline, 98%
| 580-16-5 |
|
DL-1-Aminoindane-1-Carboxylic Acid Hydrate, 98%
| 0-01-1 |
|
Maleic anhydride
| 108-31-6 |
|
2-Methyl-5-Nitroaniline, 96%
| 99-55-8 |
|
Heptane, for HPLC (99% n-Heptane)
| 142-82-5 |
|
beta-Nicotinamide Adenine Dinucleotide, Sodium Salt
| 20111-18-6 |
|
1-Bromopentadecane
| 629-72-1 |
|
2-Chlorobenzothiazole, 99%
| 615-20-3 |
|
2-Methylresorcinol, 98%
| 608-25-3 |
|
Ruthenium(III) nitrosyl nitrate, in diluted Nitric acid
| 7697-37-2 |
|
Ciprofibrate
| 52214-84-3 |
|
1-(4-Methylphenyl)-2-methylpiperazine
| 35947-11-6 |
|
|